Xbiotech, Inc.
Clinical trials sponsored by Xbiotech, Inc., explained in plain language.
-
Can a targeted antibody give pancreatic cancer chemo a boost?
Disease control CompletedThis trial is testing whether adding an experimental antibody called XB2001 to a standard chemotherapy regimen can help people with advanced pancreatic cancer. The study has two parts: first, it finds the safest dose of XB2001, then it compares the antibody plus chemo against a p…
Phase: PHASE1, PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Experimental antibody targets deadly staph infections
Disease control CompletedThis study tested a lab-made antibody called 514G3 in 52 hospitalized adults with Staphylococcus aureus bloodstream infections. Participants received either a single dose of the antibody plus standard antibiotics or a placebo plus antibiotics. The main goals were to check safety …
Phase: PHASE1, PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a natural antibody quiet inflammation? a new trial investigates
Knowledge-focused CompletedThis early-stage trial is testing whether Natrunix, an antibody that targets a key inflammatory protein called IL-1-alpha, is safe and how it behaves in the body. About 24 healthy adults will receive either Natrunix or a placebo via injection, with doses increasing across groups.…
Phase: PHASE1 • Sponsor: XBiotech, Inc. • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC